30 June,2021 04:59 PM IST | New Delhi | ANI
A vial of Covaxin | File Pic
Results of trials of the third booster dose of Bharat Biotech's Covid-19 vaccine Covaxin is expected to come by November this year, sources told ANI.
The booster dose of the indigenously manufactured vaccine was first launched in May, after which the trials began at the All India Institute of Medical Sciences (AIIMS) in Delhi and Patna. As many as 12 centres across the country are conducting trials for Covaxin's booster shot.
The permission to conduct the clinical trials for the third booster dose was granted to Bharat Biotech in April by the Drug Controller General of India (DCGI). The results of the first trial, conducted in May, will come in August.
Meanwhile, for the second trial, final results are expected by November 2021. The trials are aimed at assessing the immunogenicity, safety, reactogenicity and tolerability of the Covaxin booster dose.
ALSO READ
Bharat Biotech launches oral vaccine against cholera, targets 200 million doses
As WHO declares mpox outbreak an emergency, watch out for these symptoms
Bharat Biotech co-founder Dr. Krishna Ella awarded by Johns Hopkins
India records 441 fresh COVID-19 JN.1 variant cases, active cases has gone down
Delhi's Safdarjung hospital gears up to treat COVID-19 patients
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
